Valley National Advisers’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.42K Buy
125
+3
+2% +$200 ﹤0.01% 653
2026
Q1
$7K Buy
122
+2
+2% +$139 ﹤0.01% 651
2025
Q4
$7K Sell
120
-3
-2% -$194 ﹤0.01% 657
2025
Q3
$8K Sell
123
-6
-5% -$475 ﹤0.01% 603
2025
Q2
$11K Buy
129
+5
+4% +$392 ﹤0.01% 539
2025
Q1
$8K Buy
124
+3
+2% +$245 ﹤0.01% 589
2024
Q4
$9K Buy
121
+5
+4% +$370 ﹤0.01% 554
2024
Q3
$7K Sell
116
-152
-57% -$12.5K ﹤0.01% 557
2024
Q2
$30K Buy
268
+13
+5% +$1.64K ﹤0.01% 457
2024
Q1
$35K Buy
255
+11
+5% +$1.38K 0.01% 453
2023
Q4
$30K Buy
244
+103
+73% +$10.5K ﹤0.01% 480
2023
Q3
$13K Sell
141
-238
-63% -$26.8K ﹤0.01% 561
2023
Q2
$49K Buy
379
+95
+33% +$11.5K 0.01% 390
2023
Q1
$35K Buy
284
+14
+5% +$1.57K 0.01% 437
2022
Q4
$28K Buy
270
+7
+3% +$769 0.01% 456
2022
Q3
$25K Sell
263
-1
-0.4% -$85 0.01% 466
2022
Q2
$22K Sell
264
-20
-7% -$1.82K ﹤0.01% 464
2022
Q1
$37K Buy
284
+64
+29% +$7K 0.01% 427
2021
Q4
$30K Buy
220
+16
+8% +$2.3K 0.01% 442
2021
Q3
$28K Buy
204
+16
+9% +$2.02K 0.01% 423
2021
Q2
$20K Buy
188
+12
+7% +$1.15K ﹤0.01% 481
2021
Q1
$16K Buy
176
+60
+52% +$5.63K ﹤0.01% 484
2020
Q4
$11K Sell
116
-1,340
-92% -$120K ﹤0.01% 505
2020
Q3
$150K Sell
1,456
-500
-26% -$52.2K 0.03% 190
2020
Q2
$198K Hold
1,956
0.05% 184
2020
Q1
$132K Hold
1,956
0.04% 191
2019
Q4
$107K Hold
1,956
0.03% 240
2019
Q3
$73K Hold
1,956
0.02% 264
2019
Q2
$73K Buy
1,956
+600
+44% +$18.9K 0.02% 260
2019
Q1
$40K Hold
1,356
0.01% 301
2018
Q4
$41K Hold
1,356
0.01% 278
2018
Q3
$48K Hold
1,356
0.02% 263
2018
Q2
$32K Buy
1,356
+116
+9% +$2.46K 0.01% 296
2018
Q1
$23K Hold
1,240
0.01% 318
2017
Q4
$18K Sell
1,240
-740
-37% -$9.62K 0.01% 341
2017
Q3
$24K Hold
1,980
0.01% 309
2017
Q2
$36K Hold
1,980
0.01% 274
2017
Q1
$42K Hold
1,980
0.02% 254
2016
Q4
$30K Hold
1,980
0.01% 297
2016
Q3
$43K Hold
1,980
0.02% 238
2016
Q2
$39K Hold
1,980
0.02% 253
2016
Q1
$34K Buy
1,980
+540
+38% +$9.02K 0.02% 258
2015
Q4
$29K Hold
1,440
0.02% 258
2015
Q3
$31K Hold
1,440
0.02% 261
2015
Q2
$29K Buy
1,440
+540
+60% +$9.48K 0.02% 268
2015
Q1
$14K Buy
+900
New +$13.6K 0.01% 343

Other funds holding DXCM

Valley National Advisers's DXCM Position: Q2 2026 in Review

Valley National Advisers increased its DexCom (DXCM) stake by 2.5% in Q2 2026, buying an estimated $200 and bringing the position to 125 shares worth $8.42K. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Valley National Advisers first reported a position in DXCM in Q1 2015 and has held it in 46 quarters since. The position peaked at $198K in Q2 2020. 970 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Valley National Advisers held 125 shares of DexCom worth $8.42K as of Q2 2026.
  • Valley National Advisers bought 3 DexCom shares in Q2 2026, an estimated $200.
  • DexCom made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #653 holding.
  • Valley National Advisers first reported a position in DexCom in Q1 2015 and has held it in 46 quarters since.
  • Valley National Advisers's DexCom position peaked at $198K in Q2 2020.
  • 970 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.